Fusion Pharmaceuticals Inc. Employee-related Liabilities, Current
Fusion Pharmaceuticals Inc. had Employee-related Liabilities, Current of $2.61 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:EmployeeRelatedLiabilitiesCurrent · last filed 2024-05-07
- 2024-03-31: Employee-related Liabilities, Current $2.61M.
- 2023-12-31: Employee-related Liabilities, Current $4.96M.
- 2023-09-30: Employee-related Liabilities, Current $4.52M.
- 2023-06-30: Employee-related Liabilities, Current $3.47M.
| Period end | Employee-related Liabilities, Current |
|---|---|
| 2024-03-31 | $2.61M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $4.96M 10-Q · filed 2024-05-07 |
| 2023-09-30 | $4.52M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $3.47M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.53M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $4.14M 10-K · filed 2024-03-20 |
| 2022-09-30 | $3.65M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $2.69M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $2.25M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $3.30M 10-K · filed 2023-03-16 |
| 2021-09-30 | $2.79M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $2.42M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $1.53M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $2.55M 10-K · filed 2022-03-17 |
| 2020-09-30 | $1.52M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $1.28M 10-Q · filed 2020-08-11 |
| 2019-12-31 | $991.00K 10-K · filed 2021-03-25 |